MORELLI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 221
EU - Europa 175
AS - Asia 66
AF - Africa 1
Totale 463
Nazione #
US - Stati Uniti d'America 221
IE - Irlanda 57
VN - Vietnam 44
IT - Italia 39
SE - Svezia 24
CN - Cina 14
UA - Ucraina 12
FR - Francia 11
RU - Federazione Russa 9
FI - Finlandia 6
GB - Regno Unito 6
HK - Hong Kong 4
DE - Germania 3
BE - Belgio 2
CH - Svizzera 2
SG - Singapore 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
ES - Italia 1
LB - Libano 1
NL - Olanda 1
TR - Turchia 1
Totale 463
Città #
Chandler 64
Dublin 57
Dong Ket 44
Perugia 22
San Mateo 20
Beijing 10
Lawrence 9
Medford 9
Princeton 9
Wilmington 8
Altamura 6
Ann Arbor 6
Andover 5
Hong Kong 4
Jacksonville 4
New York 4
Saint Petersburg 4
Boardman 3
Des Moines 3
Auburn Hills 2
Brussels 2
Los Angeles 2
Nanjing 2
Naples 2
Verona 2
West Jordan 2
Woodbridge 2
Abidjan 1
Amsterdam 1
Ashburn 1
Fremont 1
Guadalajara 1
Ivrea 1
Izmir 1
Moscow 1
Ravenna 1
Redmond 1
Rome 1
Singapore 1
Totale 319
Nome #
Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison’s disease 113
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 54
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 52
Adrenal autoantibodies in primary adrenal insufficiency [Autoanticorpi anti-surrene nell’insufficienza corticosurrenalica primitiva] 50
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 47
Therapy of adrenal insufficiency: an update 40
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 39
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 38
A combined approach for thyroid fine needle aspiration: liquid based cytology, cell block and immunohistochemical methods with the implementation of the Cellient™ automated cell block system 30
Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient 28
Totale 491
Categoria #
all - tutte 1.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202029 1 1 2 2 1 0 4 5 3 6 2 2
2020/202187 0 2 4 2 19 4 1 0 5 2 3 45
2021/202284 2 15 1 6 5 0 1 24 1 2 15 12
2022/2023185 12 34 0 17 20 13 0 10 72 0 6 1
2023/202451 8 9 4 0 9 3 8 1 1 5 3 0
Totale 491